Source 1review2000Allergy
Toolkit/Oral food challenge
Oral food challenge
Also known as: double-blind, placebo-controlled oral food challenge
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Bock & Atkins ( 18) followed 32 peanut-allergic children (confirmed by double-blind, placebo-controlled oral food challenges)...
Usefulness & Problems
Why this is useful
Oral food challenge is presented as a direct clinical test of whether ingestion provokes symptoms. The review uses it to confirm allergy, assess remission, and evaluate cross-reactivity claims.; confirming clinical food allergy; testing whether serologic or skin-test positivity corresponds to clinical reactivity; assessing resolution of allergy
Source:
Oral food challenge is presented as a direct clinical test of whether ingestion provokes symptoms. The review uses it to confirm allergy, assess remission, and evaluate cross-reactivity claims.
Source:
confirming clinical food allergy
Source:
testing whether serologic or skin-test positivity corresponds to clinical reactivity
Source:
assessing resolution of allergy
Problem solved
It addresses the gap between positive immunologic tests and actual symptomatic allergy.; distinguishes true clinical reactivity from sensitization alone
Source:
It addresses the gap between positive immunologic tests and actual symptomatic allergy.
Source:
distinguishes true clinical reactivity from sensitization alone
Problem links
distinguishes true clinical reactivity from sensitization alone
LiteratureIt addresses the gap between positive immunologic tests and actual symptomatic allergy.
Source:
It addresses the gap between positive immunologic tests and actual symptomatic allergy.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Techniques
Functional AssayTarget processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
It requires controlled allergen administration and clinical monitoring.; requires supervised clinical setting and exposure to the suspected food allergen
The review does not claim that challenge testing alone explains the molecular basis of cross-reactivity.; the abstract does not provide protocol details or safety workflow
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Elimination of all legumes in individuals with clinical reactions to one legume is generally unwarranted despite frequent multiple positive legume tests.
Epitope analysis suggests that linear IgE-binding epitopes are prominent in major peanut allergens and that some single amino-acid substitutions can reduce IgE binding, implying therapeutic potential.
Molecular studies indicate that peanut and soy contain both homologous and unique allergenic proteins, helping explain why serologic cross-reactivity does not always produce clinical coallergy.
Serologic or skin-test cross-reactivity between peanut and soy is common, but clinically important peanut-soy coallergy is uncommon.
clinical soy reactivity in peanut allergic children 3%coallergy rate atopic dermatitis cohort 1 0.8%coallergy rate atopic dermatitis cohort 2 1.8%soy reactivity among severe peanut allergy cases 6.5%
Approval Evidence
1 source2 linked approval claimsfirst-pass slug oral-food-challenge
Bock & Atkins ( 18) followed 32 peanut-allergic children (confirmed by double-blind, placebo-controlled oral food challenges)...
Source:
review summarysupports
Elimination of all legumes in individuals with clinical reactions to one legume is generally unwarranted despite frequent multiple positive legume tests.
Source:
review summarysupports
Serologic or skin-test cross-reactivity between peanut and soy is common, but clinically important peanut-soy coallergy is uncommon.
Source:
Comparisons
Source-stated alternatives
The review contrasts oral challenge results with skin prick testing, RAST, and immunoblot-based molecular analyses.
Source:
The review contrasts oral challenge results with skin prick testing, RAST, and immunoblot-based molecular analyses.
Source-backed strengths
used repeatedly in the review as the standard for confirming peanut or soy clinical reactivity
Source:
used repeatedly in the review as the standard for confirming peanut or soy clinical reactivity
Compared with Immunoblot
The review contrasts oral challenge results with skin prick testing, RAST, and immunoblot-based molecular analyses.
Shared frame: source-stated alternative in extracted literature
Strengths here: used repeatedly in the review as the standard for confirming peanut or soy clinical reactivity.
Relative tradeoffs: the abstract does not provide protocol details or safety workflow.
Source:
The review contrasts oral challenge results with skin prick testing, RAST, and immunoblot-based molecular analyses.
Compared with Skin prick test
The review contrasts oral challenge results with skin prick testing, RAST, and immunoblot-based molecular analyses.
Shared frame: source-stated alternative in extracted literature
Strengths here: used repeatedly in the review as the standard for confirming peanut or soy clinical reactivity.
Relative tradeoffs: the abstract does not provide protocol details or safety workflow.
Source:
The review contrasts oral challenge results with skin prick testing, RAST, and immunoblot-based molecular analyses.
Ranked Citations
- 1.